Title
Category
Credits
Event date
Cost
  • Psychopharmacology
  • Side Effects
  • Depression
  • Bipolar Disorder
  • Diagnostic Tools
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Join Dr Goldberg as he reviews factors that impact the diagnosis of bipolar disorder and current treatments for bipolar depression in adults.
  • Psychopharmacology
  • Side Effects
  • Child and Adolescent Psychiatry
  • Depression
  • Bipolar Disorder
  • Diagnostic Tools
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What are the evidence-based pharmacologic treatment approaches for pediatric patients with bipolar depression?
  • Patient/Physician Communication
  • Mood Disorders
  • Child and Adolescent Psychiatry
  • Depression
  • Bipolar Disorder
  • Antipsychotics
  • Antidepressants
  • Diagnostic Tools
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Drs Findling and Goldberg offer expertise on the diagnosis and treatment of bipolar disorder in patients of all ages.
  • Muscular Dystrophy
  • Psychopharmacology
  • Patient/Physician Communication
  • Obsessive-Compulsive and Related Disorders
  • Violence/Aggression
  • Sleep
  • Side Effects
  • Delivery of Care
  • Cognition
  • Child and Adolescent Psychiatry
  • Depression
  • Attention-Deficit/Hyperactivity Disorder
  • Diagnostic Tools
  • Weight
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
This video reviews treatment guidelines for patients with DMD and emphasizes the importance of clinicians intervening early on behalf of individuals who develop behavioral-psychosocial comorbidities.
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Bipolar Disorder
  • Diagnostic Tools
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What features may predict bipolar disorder vs schizophrenia in a person with first-episode psychosis? In this journal CME activity, find out which tools could most aid diagnosis.
  • Patient/Physician Communication
  • Neurology
  • Neuroimaging
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Geriatric Psychiatry
  • Functional Impairment
  • Diagnostic Tools
  • Education
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Drs Anderson and Malone cover the types of dementia and their indicators, ways to approach care for mild cognitive impairment (MCI) and mild dementia, and treatment options available or in the pipeline for disease intervention. Early diagnosis and intervention of MCI and mild dementia can slow disease progression and optimize outcomes for both patients and caregivers.
  • Patient/Physician Communication
  • Neurology
  • Neuroimaging
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Geriatric Psychiatry
  • Functional Impairment
  • Diagnostic Tools
  • Education
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Drs Anderson and Malone discuss the burden of, signs and symptoms of, diagnostic tools and criteria for mild cognitive impairment (MCI) and mild/early dementia and the benefits of early diagnosis. Early diagnosis and intervention of MCI and mild dementia can slow disease progression and optimize outcomes for both patients and caregivers.
  • Renal Disease
  • Primary Care
  • Patient/Physician Communication
  • Side Effects
  • Cardiology
  • Metabolic Disorders
  • Diagnostic Tools
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
How to screen UACR and eGFR levels, implement selective non-steroidal MRA therapies, and mitigate the risk of hyperkalemia to prevent CKD disease progression
  • Catatonia
  • Diagnostic Tools
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Underdiagnosis of catatonia may occur because of its heterogeneous phenotypes and a lack of harmony between the DSM-5 and the Bush-Francis Catatonia Rating Scale.
  • Alzheimer Disease
  • Dementia
  • Diagnostic Tools
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Great strides in research on Alzheimer disease diagnostic biomarkers and treatment targets have taken place over the past 2 decades. Listen as Dr Goldfarb highlights exciting developments.

Pages